Neighbors Rush to Help During Massive Fire at Pa. Senior Living Center
Dozens of neighbors rushed to the scene of a massive late-night fire that injured at least 20 people at a Pennsylvania senior living community, wrapping the elderly in blankets and carrying them to ambulances in makeshift gurneys.
Larry Kingsland, 62, said Friday he and scores of people who live around the Barclay Friends Senior Living Community ferried elderly residents to medics as firefighters rescued them from the blaze.
"Everyone saw how devastating the fire was and we all had the same reaction: that people needed help," he said of the Thursday night inferno in West Chester, about 35 miles (56 kilometers) west of Philadelphia. "The whole neighborhood was helping."
Firefighters were still dousing smoldering hot spots on what remains of the building late Friday morning. The fire was declared under control just before 1:30 a.m. An investigation into what caused the blaze is underway, a town fire chief said.
Opioid Addiction Treatments Face Off in US Trial
The first U.S. study to compare two treatments for opioid addiction finds a monthly shot works as well as a daily drug to prevent relapse.
The shot requires days of detox first and that proved to be a stumbling block for many. For those who made it past that hurdle, the shot Vivitrol worked about the same as an older treatment, Suboxone.
Both drugs had high relapse rates and there were overdoses, including fatal ones, in the experiment in 570 adults. The study , published Tuesday in the journal Lancet, is the first to compare the two drugs in the United States, where an opioid addiction epidemic has doctors and policymakers deeply divided over treatment strategies.
Many addiction treatment programs don't offer either medication, or only one of them.
Study Suggests Women Less Likely to Get CPR From Bystanders
Women are less likely than men to get CPR from a bystander and more likely to die, a new study suggests, and researchers think reluctance to touch a woman's chest might be one reason.
Only 39 percent of women suffering cardiac arrest in a public place were given CPR versus 45 percent of men, and men were 23 percent more likely to survive, the study found.
It involved nearly 20,000 cases around the country and is the first to examine gender differences in receiving heart help from the public versus professional responders.
"It can be kind of daunting thinking about pushing hard and fast on the center of a woman's chest" and some people may fear they are hurting her, said Audrey Blewer, a University of Pennsylvania researcher who led the study.
Rescuers also may worry about moving a woman's clothing to get better access, or touching breasts to do CPR, but doing it properly "shouldn't entail that," said another study leader, U Penn's Dr. Benjamin Abella. "You put your hands on the sternum, which is the middle of the chest. In theory, you're touching in between the breasts."
Get Ahead of Stroke Campaign Debuts App to Help EMS Assess Stroke Severity
The Get Ahead of Stroke campaign has debuted an app to help EMS first responders transport and triage patients quickly to stroke centers equipped to treat severe strokes.
Called Stroke Scales for EMS, the app is designed to assist first responders in assessing stroke severity in emergency situations and, in cases of severe stroke, transport patients to neuroendovascular-ready stroke facilities.
“Stroke is a leading cause of death and disability nationwide. This app will help first responders quickly and accurately identify cases of severe stroke so they can transport patients to appropriate treatment right away,” said Dr. Blaise Baxter, a neurointerventional radiologist and the President of the Society of NeuroInterventional Surgery.
To determine how to properly triage a patient experiencing a stroke, first responders and emergency personnel can use the app to assess the severity of the stroke through one of several “stroke scales.” These scales measure certain physical indicators that can point to a patient having a large vessel occlusion, including the ability to squeeze and release a hand, control eye movement, make facial expressions, feel a pin prick and more. Based on results from the stroke scale, the app recommends the type of facility where a stroke patient can receive appropriate treatment.
The app is available for download on the iOS App Store and Google Play.
Walgreens Now Selling Naloxone Over the Counter
ABC News reported that the opioid overdose reversal drug will be available without a prescription in 45 states, and Walgreens said they are “eager and willing” to work with other states to make naloxone widely accessible.
"By stocking Narcan in all our pharmacies, we are making it easier for families and caregivers to help their loved ones by having it on hand in case it is needed,"
Walgreens said in a statement. "As a pharmacy, we are committed to making Narcan more accessible in the communities we serve."
U.S. Vaccine Panel to Discuss Waning Effectiveness, New Shots
Two years ago, George Green got stabbing pain and bad blisters around his right arm. It was the worst case of shingles his doctor had ever seen.
"I said, 'Wait a minute, I had the vaccine! How come I got this?'" recalled Green, a 68-year-old engineer in Austell, Georgia, who got the shot seven years earlier.
His doctor at Emory University, Dr. Sharon Bergquist, said about 10 percent of the patients she's given the shingles shot have come back with the disease years later.
No vaccine is perfect, and it can take many years to find out how well a new vaccine works and how long it lasts. Sometimes, health officials have called for an additional dose when it became clear the first round wasn't cutting it. But disappointing performance is also prompting drugmakers to pursue new vaccines for older patients, using new additives to boost effectiveness.
Research: Spider Venom May Offer Stroke Therapy
SYDNEY, Australia — The venom of one of the world's deadliest spiders, the Australian funnel-web, may be used to treat nervous-system disorders including pain, epilepsy and stroke, according to Australian scientists.
Researchers at the University of Queensland Institute for Molecular Bioscience have found that spider venom, because it specifically targets the nervous system to paralyse prey, is more effective than man-made drugs in treating nervous system disorders.